Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients

Nephrology Dialysis Transplantation

Volumn 27, Issue 9, 2012, Pages 3615-3620

  Huang, Xiaoyan ^a   Stenvinkel, Peter ^a   Qureshi, Abdul Rashid ^a   Risérus, Ulf ^b   Cederholm, Tommy ^b   Bárány, Peter ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Carrero, Juan Jesús ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

competing risk models; end stage renal disease; inflammation; mortality; polyunsaturated fatty acids

Indexed keywords

5,8,11 ICOSATRIENOIC ACID; INTERLEUKIN 6; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; VEGETABLE OIL;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FOLLOW UP; GAS LIQUID CHROMATOGRAPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY TRANSPLANTATION; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PHOSPHOLIPID BLOOD LEVEL; POST HOC ANALYSIS; PRIORITY JOURNAL; SWEDEN; TREATMENT DURATION;

ADULT; AGED; CHROMATOGRAPHY, GAS; CROSS-SECTIONAL STUDIES; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE;

EID: 84865759967     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs132     Document Type: Article

References (52)

1. Morbidity & mortality. Am J Kidney Dis 2011; 57: e301-e310.
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32: S112-S119.
3. Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J Intern Med 2010; 268: 456-467.
4. Stenvinkel P, Carrero JJ, Axelsson J et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3: 505-521.
5. Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009; 4: S49-S55.
6. Fouque D, Kalantar-Zadeh K, Kopple J et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398.
7. Carrero JJ. Mechanisms of altered regulation of food intake in chronic kidney disease. J Ren Nutr 2011; 21: 7-11.
8. Lichtenstein AH, Appel LJ, Brands M et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96.
9. Kushi LH, Lew RA, Stare FJ et al. Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study. N Engl J Med 1985; 312: 811-818.
10. Hu FB, Stampfer MJ, Manson JE et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-1499.
11. Kris-Etherton PM, Harris WS, Appel LJ et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757.
12. Harris WS, Mozaffarian D, Rimm E et al. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009; 119: 902-907.
13. Khoueiry G, Waked A, Goldman M et al. Dietary intake in hemodialysis patients does not reflect a heart healthy diet. J Ren Nutr 2011; 21: 438-447.
14. Friedman AN, Moe SM, Perkins SM et al. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis 2006; 47: 1064-1071.
15. Goris AH, Westerterp-Plantenga MS, Westerterp KR. Undereating and underrecording of habitual food intake in obese men: selective underreporting of fat intake. Am J Clin Nutr 2000; 71: 130-134.
16. Ma J, Folsom AR, Shahar E et al. Plasma fatty-acid composition as an indicator of habitual dietary-fat intake in middle-aged adults. Am J Clin Nutr 1995; 62: 564-571.
17. Friedman AN, Saha C, Watkins BA. Feasibility study of erythrocyte long-chain omega-3 polyunsaturated fatty acid content and mortality risk in hemodialysis patients. J Ren Nutr 2008; 18: 509-512.
18. Hamazaki K, Terashima Y, Itomura M et al. Docosahexaenoic acid is an independent predictor of all-cause mortality in hemodialysis patients. Am J Nephrol 2011; 33: 105-110.
19. Shearer GC, Carrero JJ, Heimburger O et al. Plasma fatty acids in chronic kidney disease: nervonic acid predicts mortality. J Ren Nutr 2012; 22: 277-283.
20. Stenvinkel P, Heimburger O, Paultre F et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Qureshi AR, Alvestrand A, Danielsson A et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53: 773-782.
23. Boberg M, Croon LB, Gustafsson IB et al. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci (Lond) 1985; 68: 581-587.
24. Smedman AE, Gustafsson IB, Berglund LG et al. Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999; 69: 22-29.
25. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr Opin Lipidol 2003; 14: 15-19.
26. James MJ, Gibson RA, D'Angelo M et al. Simple relationships exist between dietary linoleate and the n-6 fatty acids of human neutrophils and plasma. Am J Clin Nutr 1993; 58: 497-500.
27. Siguel EN, Chee KM, Gong JX et al. Criteria for essential fatty-acid deficiency in plasma as assessed by capillary column gas-liquidchromatography. Clin Chem 1987; 33: 1869-1873.
28. Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics 2001; 57: 114-119.
29. Heinze G, Dunkler D. Avoiding infinite estimates of time-dependent effects in small-sample survival studies. Stat Med 2008; 27: 6455-6469.
30. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
31. An WS, Kim SE, Kim KH et al. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Ren Nutr 2009; 19: 267-274.
32. Petersson H, Basu S, Cederholm T et al. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men. Br J Nutr 2008; 99: 1186-1189.
33. Petersson H, Lind L, Hulthe J et al. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 2009; 203: 298-303.
34. Kalogeropoulos N, Panagiotakos DB, Pitsavos C et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin Chim Acta 2010; 411: 584-591.
35. Laaksonen DE, Nyyssonen K, Niskanen L et al. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch Intern Med 2005; 165: 193-199.
36. Oh K, Hu FB, Manson JE et al. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study. Am J Epidemiol 2005; 161: 672-679.
37. Ascherio A, Rimm EB, Giovannucci EL et al. Dietary fat and risk of coronary heart disease in men: Cohort follow up study in the United States. BMJ 1996; 313: 84-90.
38. Warensjo E, Sundstrom J, Vessby B et al. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. Am J Clin Nutr 2008; 88: 203-209.
39. Mensink RP, Zock PL, Kester ADM et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155.
40. Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 2009; 48: 44-51.
41. Grimsgaard S, Bonaa KH, Jacobsen BK et al. Plasma saturated and linoleic fatty acids are independently associated with blood pressure. Hypertension 1999; 34: 478-483.
42. Hammarstrom S. Conversion of 5,8,11-eicosatrienoic acid to leukotrienes C3 and D3. J Biol Chem 1981; 256: 2275-2279.
43. Noori N, Dukkipati R, Kovesdy CP et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis 2011; 58: 248-256.
44. Fassett RG, Gobe GC, Peake JM et al. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 2010; 56: 728-742.
45. Friedman AN. Omega-3 fatty acid supplementation in advanced kidney disease. Semin Dial 2010; 23: 396-400.
46. Madsen T, Christensen JH, Svensson M et al. Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study. J Ren Nutr 2011; 21: 169-175.
47. Becher W, Pearson M. Riksmaten 1997-1998. Kostvanor Och Näringsintag I Sverige. (National Survey of Dietary Habits and Nutrient Intake in Sweden). Uppsala, Sweden: Livsmedelsverket (National food administration). http://www.slv.se/en-gb/group1/food-andnutrition/dietary-surveys1/ riksmaten-1997-98-dietary-habits-and-nutrient-intakein-sweden/
48. Kutner NG, Clow PW, Zhang R et al. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis 2002; 39(5): 1018-1024.
49. Calder PC, Deckelbaum RJ. Harmful, harmless or helpful? The n-6 fatty acid debate goes on. Curr Opin Clin Nutr Metab Care 2011; 14: 113-114.
50. Begum R, Belury MA, Burgess JR et al. Supplementation with n-3 and n-6 polyunsaturated fatty acids: effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients. J Ren Nutr 2004; 14: 233-241.
51. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7: e1000252.
52. Bjermo H, Iggman D, Kullberg J et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am J Clin Nutr 2012; 95: 1-10.